申请人:Bristol-Myers Squibb Company
公开号:US10077287B2
公开(公告)日:2018-09-18
Tubulysin analogs of the formula (I)
where R1, R2 R3, R4, R5, R6, R7, and Y are as defined herein, are anti-mitotic agents that can be used in the treatment of cancer, especially when conjugated to a targeting moiety.
式 (I) 的 Tubulysin 类似物
其中 R1、R2、R3、R4、R5、R6、R7 和 Y 如本文所定义,是可用于治疗癌症的抗有丝分裂剂,尤其是与靶向分子共轭时。